BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18216243)

  • 1. Molecular switch for CLC-K Cl- channel block/activation: optimal pharmacophoric requirements towards high-affinity ligands.
    Liantonio A; Picollo A; Carbonara G; Fracchiolla G; Tortorella P; Loiodice F; Laghezza A; Babini E; Zifarelli G; Pusch M; Camerino DC
    Proc Natl Acad Sci U S A; 2008 Jan; 105(4):1369-73. PubMed ID: 18216243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular requisites for drug binding to muscle CLC-1 and renal CLC-K channel revealed by the use of phenoxy-alkyl derivatives of 2-(p-chlorophenoxy)propionic acid.
    Liantonio A; Accardi A; Carbonara G; Fracchiolla G; Loiodice F; Tortorella P; Traverso S; Guida P; Pierno S; De Luca A; Camerino DC; Pusch M
    Mol Pharmacol; 2002 Aug; 62(2):265-71. PubMed ID: 12130677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of sites responsible for the potentiating effect of niflumic acid on ClC-Ka kidney chloride channels.
    Zifarelli G; Liantonio A; Gradogna A; Picollo A; Gramegna G; De Bellis M; Murgia AR; Babini E; Camerino DC; Pusch M
    Br J Pharmacol; 2010 Aug; 160(7):1652-61. PubMed ID: 20649569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation and inhibition of kidney CLC-K chloride channels by fenamates.
    Liantonio A; Picollo A; Babini E; Carbonara G; Fracchiolla G; Loiodice F; Tortorella V; Pusch M; Camerino DC
    Mol Pharmacol; 2006 Jan; 69(1):165-73. PubMed ID: 16244177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting kidney CLC-K channels: pharmacological profile in a human cell line versus Xenopus oocytes.
    Imbrici P; Liantonio A; Gradogna A; Pusch M; Camerino DC
    Biochim Biophys Acta; 2014 Oct; 1838(10):2484-91. PubMed ID: 24863058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations of pharmacologic properties of the renal CLC-K1 chloride channel co-expressed with barttin by the use of 2-(p-Chlorophenoxy)propionic acid derivatives and other structurally unrelated chloride channels blockers.
    Liantonio A; Pusch M; Picollo A; Guida P; De Luca A; Pierno S; Fracchiolla G; Loiodice F; Tortorella P; Conte Camerino D
    J Am Soc Nephrol; 2004 Jan; 15(1):13-20. PubMed ID: 14694153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of interaction of niflumic acid with heterologously expressed kidney CLC-K chloride channels.
    Picollo A; Liantonio A; Babini E; Camerino DC; Pusch M
    J Membr Biol; 2007 Apr; 216(2-3):73-82. PubMed ID: 17659402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural requisites of 2-(p-chlorophenoxy)propionic acid analogues for activity on native rat skeletal muscle chloride conductance and on heterologously expressed CLC-1.
    Liantonio A; De Luca A; Pierno S; Didonna MP; Loiodice F; Fracchiolla G; Tortorella P; Antonio L; Bonerba E; Traverso S; Elia L; Picollo A; Pusch M; Camerino DC
    Br J Pharmacol; 2003 Aug; 139(7):1255-64. PubMed ID: 12890704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney CLC-K chloride channels inhibitors: structure-based studies and efficacy in hypertension and associated CLC-K polymorphisms.
    Liantonio A; Imbrici P; Camerino GM; Fracchiolla G; Carbonara G; Giannico D; Gradogna A; Mangiatordi GF; Nicolotti O; Tricarico D; Pusch M; Camerino DC
    J Hypertens; 2016 May; 34(5):981-92. PubMed ID: 26991533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping ligand binding pockets in chloride ClC-1 channels through an integrated in silico and experimental approach using anthracene-9-carboxylic acid and niflumic acid.
    Altamura C; Mangiatordi GF; Nicolotti O; Sahbani D; Farinato A; Leonetti F; Carratù MR; Conte D; Desaphy JF; Imbrici P
    Br J Pharmacol; 2018 May; 175(10):1770-1780. PubMed ID: 29500929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A regulatory calcium-binding site at the subunit interface of CLC-K kidney chloride channels.
    Gradogna A; Babini E; Picollo A; Pusch M
    J Gen Physiol; 2010 Sep; 136(3):311-23. PubMed ID: 20805576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular determinants of differential pore blocking of kidney CLC-K chloride channels.
    Picollo A; Liantonio A; Didonna MP; Elia L; Camerino DC; Pusch M
    EMBO Rep; 2004 Jun; 5(6):584-9. PubMed ID: 15167890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of chloride channels belonging to the ClC family by the use of chiral clofibric acid derivatives.
    Pusch M; Liantonio A; Bertorello L; Accardi A; De Luca A; Pierno S; Tortorella V; Camerino DC
    Mol Pharmacol; 2000 Sep; 58(3):498-507. PubMed ID: 10953042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Niflumic acid inhibits chloride conductance of rat skeletal muscle by directly inhibiting the CLC-1 channel and by increasing intracellular calcium.
    Liantonio A; Giannuzzi V; Picollo A; Babini E; Pusch M; Conte Camerino D
    Br J Pharmacol; 2007 Jan; 150(2):235-47. PubMed ID: 17128287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Pharmacology of Kidney and Inner Ear CLC-K Chloride Channels.
    Gradogna A; Pusch M
    Front Pharmacol; 2010; 1():130. PubMed ID: 21833170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A common sequence variation of the CLCNKB gene strongly activates ClC-Kb chloride channel activity.
    Jeck N; Waldegger P; Doroszewicz J; Seyberth H; Waldegger S
    Kidney Int; 2004 Jan; 65(1):190-7. PubMed ID: 14675050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacovigilance database search discloses ClC-K channels as a novel target of the AT
    Imbrici P; Tricarico D; Mangiatordi GF; Nicolotti O; Lograno MD; Conte D; Liantonio A
    Br J Pharmacol; 2017 Jul; 174(13):1972-1983. PubMed ID: 28334417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Channel or transporter? The CLC saga continues.
    Pusch M; Zifarelli G; Murgia AR; Picollo A; Babini E
    Exp Physiol; 2006 Jan; 91(1):149-52. PubMed ID: 16179405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A selective class of inhibitors for the CLC-Ka chloride ion channel.
    Koster AK; Wood CAP; Thomas-Tran R; Chavan TS; Almqvist J; Choi KH; Du Bois J; Maduke M
    Proc Natl Acad Sci U S A; 2018 May; 115(21):E4900-E4909. PubMed ID: 29669921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the mouse ClC-K1/Barttin chloride channel.
    L'Hoste S; Diakov A; Andrini O; Genete M; Pinelli L; Grand T; Keck M; Paulais M; Beck L; Korbmacher C; Teulon J; Lourdel S
    Biochim Biophys Acta; 2013 Nov; 1828(11):2399-409. PubMed ID: 23791703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.